Drug-resistant malaria

被引:146
作者
Hyde, JE [1 ]
机构
[1] Univ Manchester, Fac Life Sci, Manchester M60 1QD, Lancs, England
基金
英国惠康基金;
关键词
D O I
10.1016/j.pt.2005.08.020
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
In the past 21 years, a modest increase in the range of antimalarial drugs approved for clinical use has been complemented by a more impressive expansion in the analysis and understanding of the molecular mechanisms underlying resistance to these agents. Such resistance is a major factor in the increasing difficulty in controlling malaria, and important developments during this period are recounted here.
引用
收藏
页码:494 / 498
页数:5
相关论文
共 48 条
[1]   A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzyme-linked immunosorbent assay-based technology [J].
Alifrangis, M ;
Enosse, S ;
Pearce, R ;
Drakeley, C ;
Roper, C ;
Khalil, IF ;
Nkya, WMMM ;
Ronn, AM ;
Theander, TG ;
Bygjerg, IBC .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (02) :155-162
[2]   Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets [J].
Alifrangis, M ;
Lemnge, MM ;
Ronn, AM ;
Segeja, MD ;
Magesa, SM ;
Khalil, IF ;
Bygbjerg, IC .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2003, 69 (03) :238-243
[3]   Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial [J].
Alloueche, A ;
Bailey, W ;
Barton, S ;
Bwika, J ;
Chimpeni, P ;
Falade, CO ;
Fehintola, FA ;
Horton, J ;
Jaffar, S ;
Kanyok, T ;
Kremsner, PG ;
Kublin, JG ;
Lang, T ;
Missinou, MA ;
Mkandala, C ;
Oduola, AMJ ;
Premji, Z ;
Robertson, L ;
Sowunmi, A ;
Ward, SA ;
Winstanley, PA .
LANCET, 2004, 363 (9424) :1843-1848
[4]  
AMBROISETHOMAS P, 1996, PARSITOL TODAY, V2, P79
[5]   Antimalarial chemotherapy: young guns or back to the future? [J].
Biagini, GA ;
O'Neill, PM ;
Nzila, A ;
Ward, SA ;
Bray, PG .
TRENDS IN PARASITOLOGY, 2003, 19 (11) :479-487
[6]   Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance [J].
Bray, PG ;
Martin, RE ;
Tilley, L ;
Ward, SA ;
Kirk, K ;
Fidock, DA .
MOLECULAR MICROBIOLOGY, 2005, 56 (02) :323-333
[7]   Conservation of a novel vacuolar transporter in Plasmodium species and its central role in chloroquine resistance of P-falciparum [J].
Carlton, JMR ;
Fidock, DA ;
Djimdé, A ;
Plowe, CV ;
Wellems, TE .
CURRENT OPINION IN MICROBIOLOGY, 2001, 4 (04) :415-420
[8]   Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America [J].
Cortese, JF ;
Caraballo, A ;
Contreras, CE ;
Plowe, CV .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (07) :999-1006
[9]   Transfection technology and the study of drug resistance in the malaria parasite Plasmodium falciparum [J].
Crabb, BS .
DRUG RESISTANCE UPDATES, 2002, 5 (3-4) :126-130
[10]  
Davis TME, 2005, DRUGS, V65, P75, DOI 10.2165/00003495-200565010-00004